Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enbrel in RA patients failing Infliximab
NCT00099554Phase 4Completed
- Sponsor
- Amgen
- Start
- May 2004
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), sponsored by Amgen. Started May 2004; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00099554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099554.